| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.8B | $0.9B | $0.8B | $0.6B | $0.4B | $0.1B | $0.1B |
| Cost of Revenue | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | $0.0B |
| Net Income | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $0.69 | $1.18 | $1.58 | $0.99 | $1.13 | — | $0.17 | $-0.16 |
| EPS (Diluted) | $0.69 | $1.18 | $1.48 | $0.99 | $0.98 | — | $0.13 | $-0.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $5.4B | $5.9B | $6.1B | $5.6B | $3.5B | $3.1B | $2.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $3.5B | $3.6B | $3.8B | $3.7B | $3.1B | $2.1B | $1.6B | $1.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $0.9B | $1.1B | $1.4B | $1.6B | $1.8B | $1.0B | $0.9B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $0.0B | $0.4B | $0.2B | $-0.6B | $-2.0B | $-0.5B | $-0.4B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.4B | $-0.8B | $-0.6B | $0.2B | $1.7B | $0.3B | $0.2B | $0.4B |